http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630033-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53ea8c349a76ee077b1143f1fc519498 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
| filingDate | 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91dae932057e4f9eeb9d66b04249cd04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de322220033ee6c0da83461b08c31c09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b437202f99b22600ac1ce1f87c1d0cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48335a2310414f17674542cc74bb54a |
| publicationDate | 2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2630033-C1 |
| titleOfInvention | Method for treatment of rhegmatogenous retinal detachment with intrascleral introduction of viscoelastic |
| abstract | FIELD: medicine. n SUBSTANCE: method includes a scleral incision in the retinal rupture projection, which is made at a depth of 2/3 of its thickness. Then, an intrascleral tunnel is formed in the retinal fracture projection corresponding to its size, by delamination. Then viscoelastic is injected into the tunnel under ophthalmoscopic control using a 120 D contactless lens. Administration is performed until the retinal rupture is completely blocked and the rupture edges are located on the scleral depression shaft. Then a single cross-shaped suture is applied to the sclera and the conjunctiva is sutured with a continuous suture; on the second day after viscoelastic introduction transpupillary limiting laser coagulation of the retina is performed around the retinal rupture with the following radiation parameters: power - 120-240 mW, spot diameter in focus - 200-300 mkm, exposure - 0.05-0.1 s, with laser coagulants superimposed in three or four rows in staggered order at a distance of 0.5-1 coagulum diameter. n EFFECT: invention allows to reduce operational and postoperative complications, such as damage to the choroid with subretinal hemorrhage development, damage to the vorticoid vein ampulla, formation of decubitus sores at the depression site. n 2 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2653818-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-181749-U1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2674381-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684361-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2730932-C1 |
| priorityDate | 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.